| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.877 | 19.981 | 30.086 | 25.939 | 42.058 | 80.904 | 147.247 | 162.256 |
| Total Income - EUR | - | - | 1.877 | 19.981 | 30.086 | 26.544 | 42.087 | 81.387 | 147.518 | 162.483 |
| Total Expenses - EUR | - | - | 1.107 | 7.847 | 11.267 | 11.115 | 28.786 | 33.897 | 54.774 | 79.282 |
| Gross Profit/Loss - EUR | - | - | 770 | 12.134 | 18.818 | 15.429 | 13.301 | 47.490 | 92.744 | 83.200 |
| Net Profit/Loss - EUR | - | - | 713 | 11.535 | 17.916 | 15.175 | 12.889 | 46.034 | 91.301 | 78.425 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Ocludent Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 3.086 | 2.712 | 1.114 | 29.955 | 20.795 | 41.160 | 25.520 |
| Current Assets | - | - | 813 | 9.390 | 28.763 | 44.514 | 11.060 | 68.726 | 134.010 | 112.617 |
| Inventories | - | - | 0 | 691 | 21 | 21 | 20 | 0 | 35 | 193 |
| Receivables | - | - | 0 | 284 | 789 | 6.512 | 6.042 | 43.425 | 97.515 | 81.368 |
| Cash | - | - | 813 | 8.416 | 27.953 | 37.981 | 4.998 | 25.302 | 36.460 | 31.056 |
| Shareholders Funds | - | - | 757 | 12.278 | 29.956 | 44.563 | 17.524 | 46.083 | 91.368 | 78.474 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 56 | 198 | 1.790 | 2.309 | 25.259 | 45.669 | 85.165 | 61.316 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Ocludent Medical Srl